DGAP-News

Immunic AG: Immunic successfully closes 17.5 million Euro Series A financing round (news with additional features) - Seite 3

Bavarian LfA Förderbank. As the venture capital organization of Germany's
State of Bavaria, Bayern Kapital provides equity capital financing for the
founders of young innovative technology companies in Bavaria. Presently
Bayern Kapital manages ten investment funds with a total volume of around
EUR 340 million. So far, it has invested almost EUR 227 million in 245
innovative companies in the fields of technology in various sectors
including life science, software & IT, medical technology, materials and
new materials, nanotechnology and environmental technology. This way,
almost 5,000 long-term jobs in sustainable companies have been created in
Bavaria.

www.bayernkapital.de

Dr. Reinhard Saller, [phone], bayernkapital@wuelfing-
kommunikation.de

About High-Tech Gründerfonds

High-Tech Gründerfonds invests in young, high potential high-tech start-
ups. The seed financing provided is designed to enable start-ups to take an
idea through prototyping and to market launch. Typically, High-Tech
Gründerfonds invests EUR 600,000 in the seed stage, with the potential for
up to a total of EUR 2 million per portfolio company in follow-on
financing. Investors in this public/private partnership include the Federal
Ministry of Economics and Energy, the KfW Banking Group, as well as
strategic corporate investors including ALTANA, BASF, Bayer, B. Braun,
Robert Bosch, CEWE, Daimler, Deutsche Post DHL, Deutsche Telekom, Evonik,
Lanxess, media + more venture Beteiligungs GmbH & Co. KG, METRO, Qiagen,
RWE Innogy, SAP, Tengelmann and Carl Zeiss. High-Tech Gründerfonds has
about EUR 576 million under management in two funds (EUR 272 million HTGF
I, EUR 304 million HTGF II).

www.high-tech-gruenderfonds.de

Dr. Lena Krzyzak, [phone], [e-mail]


---------------------------------------------------------------------------

Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=TQHPMNBXWM
Document title: Immunic_Financing_ENG

---------------------------------------------------------------------------

27.09.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

505715 27.09.2016